Leaders in Global Label Architecture
Everything else in the dossier supports a decision. The label is the decision, rendered in language the agency signs off on and holds you to. It is the legal boundary of every claim you make, the safety record your liability rests on, and the one document that has to say the same thing in forty markets at once. When the core data sheet and the local labels drift apart, the gap is not a formatting issue. It is a compliance finding, a recall risk, and a launch on hold. We build and govern the whole labeling architecture so it stays true to itself everywhere.
Great labeling is not a stack of documents. It is a governed system with a single core that every market label descends from and reconciles against. That structure is the difference between a safety update that reaches every market in weeks and one that takes a year.
The single governed source every market label is built from, and reconciled against on every change.
From the core data sheet at the top to the carton in a patient's hand, we own every layer of the labeling architecture, and the connective tissue that keeps them consistent.
DCDS and CCDS authoring, maintenance, and safety-driven updates: the master document every market label inherits from.
USPI, EU SmPC and PIL, and rest-of-world labels localized from the core, with every deviation justified and documented.
FDA SPL/XML, EU ePI, and component-based authoring so one approved change propagates cleanly to every format.
Mock-up to market-ready cartons, labels, and IFUs, with proofreading and print coordination that catch the error before the run.
Safety-label changes, reference-label monitoring, and deviation control, so a CCDS update reaches every market on the clock.
The operating model behind the documents: label committees, SOPs, tracking, and audit-ready traceability across the portfolio.
The Company Core Data Sheet is the most leveraged document you own: every word in it becomes forty local obligations. We author and maintain the DCDS and CCDS as living governance documents, write the safety changes with the precision the downstream cascade demands, and hold the core to a standard that survives translation into every market it feeds. A disciplined core is what makes everything below it fast.
A local label is not a translation of the core; it is a negotiation between the core and a national framework that has its own template, its own required sections, and its own tolerance for deviation. We author the USPI, the SmPC and PIL, and rest-of-world labels so each one satisfies its authority while every departure from the core is deliberate, justified, and on the record, rather than an accident someone finds at inspection.
Labeling has moved from documents to data. FDA SPL, EU ePI, and component-based authoring mean an approved phrase is an object with lineage, reused across formats and updated once. Done well, it collapses launch timelines and makes a safety change traceable to the sentence. Done as an afterthought, it becomes forty manual edits and a reconciliation nightmare. We build the structured-content model, generate compliant SPL and ePI, and make the architecture defensible in an inspection.
Approved text still has to become a carton, a foil, an IFU, and a Braille panel, and this is where an approved word turns into a misprinted batch. We manage artwork from mock-up to market-ready: building the components from approved labeling, proofreading against the source rather than the last version, and coordinating with print and packaging so the thing that ships matches the thing the agency approved, down to the strength on the carton.
The day a label is approved, the clock starts on the next change: a safety signal, a reference-label update from the innovator, a new authority requirement. Every one triggers a cascade from the core through every market, each with its own regulatory clock. We run that machine: monitoring reference labels, driving CCDS changes down to local implementation, and managing deviations so nothing quietly falls out of compliance while your team is looking at the next launch.
When labeling goes wrong, the cause is almost never a single bad document. It is a missing process: no label committee, no clear ownership, no trail showing why a market deviates. We build the operating model that keeps the architecture honest at scale: the labeling committee and its charter, the SOPs and RACI, the tracking system, and the audit-ready record that lets you show an inspector exactly why every label says what it says.
A first launch and an inherited portfolio put opposite kinds of pressure on a labeling system: one has no architecture yet, the other has too much of the wrong one.
At launch, the label, the SPL, the artwork, and every local variant all come due at once, against an approval date that will not move. We build the launch labeling package backward from that date: the core locked early, the regional labels and structured content developed in parallel, and the artwork sequenced so nothing waits on a signature that could have happened weeks earlier.
An acquisition, a merger, or years of local drift leaves you with labels no single core governs and differences nobody can explain. We reconstruct the architecture: reconcile every local label against a rebuilt core, document or resolve each deviation, and hand back a governed system with one source of truth, so the next safety change takes weeks instead of a year of archaeology.
Our labeling team has run global label functions inside industry and reviewed labeling from inside the agency. They have negotiated a USPI section with a division, driven a safety change to forty markets on deadline, and defended a deviation log in an inspection. You get the person who has held the whole architecture together, not a coordinator moving documents between inboxes.
Leads who have owned the CCDS and watched it cascade, and know exactly where a core change breaks a local label before it does.
Reviewers who have negotiated prescribing information from the authority's side and know which label language a division will and won't accept.
Practitioners fluent in SPL, ePI, and the major RIM and authoring platforms, from daily authoring to full structured-content migration.
Experience running labeling across dozens of markets and hundreds of SKUs, including the messy reality of acquired and legacy portfolios.
Tell us where labeling stands: a launch to build, a safety change to cascade, or a portfolio to harmonize. We'll match you with a senior labeling lead and respond within one business day. All inquiries are strictly confidential.
Our team's perspectives on core-to-local governance, structured content, and keeping a global label consistent under pressure: coming soon. In the meantime, reach out directly with a question you'd like to see addressed.
How discipline at the core decides the speed of every market label beneath it.
What SPL and ePI change about authoring, and why waiting is the expensive option.
A method for reconciling drifted labels back to one governed source of truth.